Medical research
Investigators from Merck have conducted a comprehensive systematic review of methods for forecasting non-Hodgkin lymphoma (NHL) cases in the US. The study aimed to identify the most robust projection method applicable to NHL disease settings. According to the research, validated projections of NHL cases are crucial for various stakeholders, including
Merck & Company Inc.
The US Food and Drug Administration (FDA) has approved an updated indication for Winrevair (sotatercept-csrk) to treat adults with pulmonary arterial hypertension (PAH, WHO Group 1), based on results from the Phase 3 ZENITH trial. The approval expands the label to include reductions in key clinical worsening events such as
Merck & Company Inc.
The US pharmaceutical company Merck has disclosed that it expects to pay an additional $200m in costs this year due to tariffs imposed by the Trump administration and retaliatory tariffs from foreign governments. The company cited a 10% tax on imports from around the world, as well as tariffs related
Pharmaceutical industry
Decision Resources, a leading research and advisory firm for pharmaceutical and healthcare issues, reports that Merck's Januvia (sitagliptin) and Novartis's Galvus (vildagliptin) will achieve blockbuster status by 2015 for the treatment of type 2 diabetes. However, these drugs, along with Takeda's Actos (pioglitazone) and
Pharmaceutical industry
Merck, a multinational pharmaceutical company, has made significant announcements in recent days, including the approval of its cervical cancer vaccine, Gardasil, by the European Commission and a partnership with India's Council of Medical Research to study the vaccine. Additionally, the company has reported revenue growth and a decrease
Pharmaceutical industry
The world's largest drug market, worth $29bn (£16bn) in the year to April, is set to face intense competition as patent protection for Merck's blockbuster cholesterol drug, Zocor, is about to expire. The expiry on Friday will allow cheaper, generic versions of the drug to flood
Pharmaceutical industry
Competition in the cholesterol treatment market has reached a fever pitch as a new study reveals that Vytorin, a joint venture between Schering-Plough and Merck, excels over Crestor, AstraZeneca's rival drug, in cutting cholesterol levels. The study, presented at the International Symposium on Atherosclerosis in Rome, highlights the
Pharmaceutical industry
A new cervical cancer vaccine, Gardasil, approved by the US Food and Drug Administration, has sparked concerns among America's religious right, who worry that immunizing young girls against the virus that causes cervical cancer may promote promiscuity. Conservative groups, including the influential Family Research Council, have voiced opposition
Pharmaceutical industry
Merck & Co. has accelerated its timeline for filing a regulatory application for its experimental combination drug MK-0431A, which aims to treat type 2 diabetes. The company had originally planned to file for approval in 2007 but now expects to submit its application to the U.S. Food and Drug
Pharmaceutical industry
Merck's €14.9 billion cash bid for Schering marks a significant move to create a stronger pharmaceutical giant. The bid, equivalent to £10 billion, represents a 15% premium to Schering's closing price last week. Merck's offer is expected to be received by Schering today,
Pharmaceutical industry
Merck, a German multinational pharmaceutical, chemical, and life sciences company, is planning a €15 billion hostile takeover bid for Schering, another German pharmaceutical company. The bid, which is the largest in the pharmaceutical industry in Europe, comes after Schering rebuffed Merck's previous friendly overtures. A merger between the
Pharmaceutical industry
Markets reacted negatively to Federal Reserve Chairman Alan Greenspan's comments on the housing boom at a Fed policy conference, with homebuilding stocks declining. Greenspan's remarks highlighted the economic imbalance caused by low risk premiums, warning that asset values could fall if investors demand higher interest rates.
